Aquarius Surgical Technologies (Aquarius Surgical Technologies) LT-Debt-to-Total-Asset : 5.03 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Aquarius Surgical Technologies LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Aquarius Surgical Technologies's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 5.03.

Aquarius Surgical Technologies's long-term debt to total assets ratio increased from Dec. 2022 (4.94) to Dec. 2023 (5.03). It may suggest that Aquarius Surgical Technologies is progressively becoming more dependent on debt to grow their business.

Aquarius Surgical Technologies LT-Debt-to-Total-Asset Historical Data

The historical data trend for Aquarius Surgical Technologies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aquarius Surgical Technologies LT-Debt-to-Total-Asset Chart

Aquarius Surgical Technologies Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

1.02

1.22

2.48

2.75

4.43

Aquarius Surgical Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															4.94	4.43	4.48	4.71	5.03

Aquarius Surgical Technologies LT-Debt-to-Total-Asset Calculation

Aquarius Surgical Technologies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

LT Debt to Total Assets (A: Mar. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2023 )	/	Total Assets (A: Mar. 2023 )
	=	2.203	/	0.497
	=	4.43

Aquarius Surgical Technologies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	2.366	/	0.47
	=	5.03

Aquarius Surgical Technologies (OTCPK:AQQRF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Aquarius Surgical Technologies LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Aquarius Surgical Technologies's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Aquarius Surgical Technologies (Aquarius Surgical Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aquarius Surgical Technologies Inc (OTCPK:AQQRF) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

ASTI:Canada

Address

89 Scollard Street, Toronto, ON, CAN, M5R 1G4

Website

https://aquariussurgical.com

Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments, principally in the field of urology. The company derives revenue from the sale of medical devices and fiber-optic delivery devices. Geographically, it has a presence in Canada, the United States, and the Dominican Republic.